BioSpace News Archive

Celcuity Inc. today announced that Brian Sullivan, Chairman, Chief Executive Officer, and Co-founder of Celcuity, will participate in the following virtual investor conferences: A company presentation at the 21st Annual Needham Healthcare Conference at 3:45 p.m. ET on Tuesday, April 12, 2022.

W. L. Gore &Associates, Inc. (“Gore”), a global materials science company, continues to build on its growing portfolio of protein capture devices with the introduction of its new 116mL and 232mL GORE ® Protein Capture Devices with Protein A.

Chinook Therapeutics, Inc., the IgA Nephropathy Foundation and Komodo Health announced an outreach initiative leveraging data and technology to drive awareness of Immunoglobulin A nephropathy and engage key medical providers at nephrology practices across the U.S.

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 11:00 am ET.

Longeveron Inc. announced the addition of K. Chris Min, M.D., Ph.D. to the Longeveron executive leadership team in the role of Chief Medical Officer, effective April 4, 2022.

Collegium Pharmaceutical, Inc., a leading, diversified specialty pharmaceutical company, announced updated financial guidance for the full year 2022 to include the expected impact of the BioDelivery Sciences International Inc. acquisition.

Pliant Therapeutics, Inc. announced that Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, will participate in a fireside chat as part of the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022, at 2:15 p.m. ET.

Humacyte, Inc. today announced the appointment of Shamik J. Parikh, M.D., as Chief Medical Officer.

Sema4 (Nasdaq: SMFR), an artificial intelligence (AI)-driven genomic and clinical data intelligence platform company, and researchers from the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York, NY recently published a study in Nature Communications using network modeling to identify novel targets for treating patients with early-stage invasive lung adenocarcinoma.

The Alliance for Sleep today announced eye-opening results from its landmark survey, Wake Up America: The Night & Day Impact of Insomnia, conducted online by The Harris Poll.